株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

血液透析・腹膜透析の世界市場 - 2024年までの予測:透析器、ダイアライザー、濃縮物、透析液、カテーテル

Hemodialysis & Peritoneal Dialysis Market by Product (Machines, Dialyzers, Concentrates, Dialysates, Catheters) Services, Modality (Conventional, CAPD, Nocturnal), End User - Global Forecasts to 2024

発行 MarketsandMarkets 商品コード 289914
出版日 ページ情報 英文 252 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.71円で換算しております。
Back to Top
血液透析・腹膜透析の世界市場 - 2024年までの予測:透析器、ダイアライザー、濃縮物、透析液、カテーテル Hemodialysis & Peritoneal Dialysis Market by Product (Machines, Dialyzers, Concentrates, Dialysates, Catheters) Services, Modality (Conventional, CAPD, Nocturnal), End User - Global Forecasts to 2024
出版日: 2019年07月02日 ページ情報: 英文 252 Pages
概要

血液透析・腹膜透析市場は、2019年の742億米ドルから、2024年までに992億米ドルまで拡大すると見られています。市場は、2019年~2024年のCAGR (複合年間成長率) で、6.0%の成長が予測されています。

当レポートでは、世界の血液透析・腹膜透析市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

289914_4.1 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET OVERVIEW_FIGURE 14

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 血液透析・腹膜透析:市場概要
  • 血液透析・腹膜透析市場シェア:タイプ別
  • 血液透析市場:製品・サービス別
  • 血液透析市場:モダリティ別
  • 腹膜透析市場:製品別
  • 腹膜透析市場:モダリティ別
  • 地域別分析:血液透析・腹膜透析市場:利用別
  • 血液透析・腹膜透析市場:国別

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 産業動向
  • 償還シナリオ
  • 規制情勢

第6章 血液透析市場

  • 血液透析市場:製品・サービス別
  • 血液透析市場:モダリティ別
  • 水処理装置市場:タイプ別

第7章 腹膜透析市場

  • 腹膜透析市場:製品・サービス別
  • 腹膜透析市場:モダリティ別

第8章 血液透析・腹膜透析市場:利用別

  • イントロダクション
  • 施設透析
  • 在宅透析

第9章 血液透析・腹膜透析市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第10章 競合情勢

  • イントロダクション
  • 市場シェア分析:主要企業別
  • 競合状況・動向
  • ベンダー概要
  • ベンダー選定基準
  • ベンダー分析
  • 競合強度

第11章 企業プロファイル

  • 旭化成メディカル (旭化成の子会社)
  • BAXTER INTERNATIONAL INC.
  • B. BRAUN MELSUNGEN AG
  • BECTON, DICKINSON AND COMPANY
  • CANTEL MEDICAL CORPORATION
  • DAVITA INC.
  • DIAVERUM
  • DIALIFE GROUP
  • FRESENIUS MEDICAL CARE AG & CO. KGAA
  • ISOPURE CORP
  • MEDTRONIC PLC
  • ニプロ
  • 日機装
  • ROCKWELL MEDICAL, INC.
  • 東レ・メディカル

第12章 付録

図表

LIST OF TABLES

  • TABLE 1: PROMINENT ACQUISITIONS IN THE DIALYSIS SERVICES INDUSTRY (2015-2017)
  • TABLE 2: DIALYSIS REIMBURSEMENT BASE ACROSS EUROPEAN COUNTRIES
  • TABLE 3: TABLE REIMBURSEMENT PER WEEK FOR DIALYSIS SERVICES IN EUROPEAN COUNTRIES (USD)
  • TABLE 4: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 5: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 6: HEMODIALYSIS SERVICES MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 7: IN-CENTER HEMODIALYSIS SERVICES MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 8: HOME HEMODIALYSIS SERVICES MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 9: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 10: HEMODIALYSIS PRODUCTS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 11: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 12: HEMODIALYSIS MACHINES MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 13: CENTER-USE HEMODIALYSIS MACHINES MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 14: HOME-USE HEMODIALYSIS MACHINES MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 15: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 16: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 17: DIALYZERS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 18: DIALYZERS MARKET, BY MATERIAL TYPE, 2017-2024 (USD BILLION)
  • TABLE 19: SYNTHETIC DIALYZERS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 20: CELLULOSE-BASED DIALYZERS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 21: DIALYZERS MARKET, BY FLUX TYPE, 2017-2024 (USD BILLION)
  • TABLE 22: HIGH-FLUX DIALYZERS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 23: LOW-FLUX DIALYZERS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 24: BLOODLINES MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 25: CONCENTRATES/DIALYSATES MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 26: ACCESS PRODUCTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 27: ACCESS PRODUCTS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 28: ARTERIOVENOUS FISTULA NEEDLES MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 29: ARTERIOVENOUS GRAFTS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 30: CENTRAL VENOUS CATHETERS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 31: OTHER HEMODIALYSIS CONSUMABLES MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 32: HEMODIALYSIS MARKET, BY MODALITY, 2017-2024 (USD BILLION)
  • TABLE 33: CONVENTIONAL LONG-TERM HEMODIALYSIS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 34: SHORT DAILY HEMODIALYSIS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 35: NOCTURNAL HEMODIALYSIS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 36: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 37: WATER TREATMENT SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 38: CENTRAL WATER DISINFECTION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 39: CENTRAL WATER DISINFECTION SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 40: CENTRAL WATER CHEMICAL DISINFECTION SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 41: CENTRAL WATER HEAT DISINFECTION SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 42: CENTRAL WATER DISINFECTION SYSTEM ACCESSORIES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 43: PORTABLE WATER DISINFECTION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 44: PORTABLE WATER DISINFECTION SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 45: PORTABLE WATER CHEMICAL DISINFECTION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 46: PORTABLE WATER HEAT DISINFECTION SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 47: PORTABLE WATER DISINFECTION SYSTEM ACCESSORIES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 48: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 49: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 50: PERITONEAL DIALYSIS PRODUCTS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 51: PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 52: PERITONEAL DIALYSIS MACHINES MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 53: PERITONEAL DIALYSIS CATHETERS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 54: PERITONEAL DIALYSIS TRANSFER SETS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 55: OTHER PERITONEAL DIALYSIS PRODUCTS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 56: PERITONEAL DIALYSIS SERVICES MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 57: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2017-2024 (USD BILLION)
  • TABLE 58: CONTINUOUS AMBULATORY PERITONEAL DIALYSIS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 59: AUTOMATED PERITONEAL DIALYSIS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 60: HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, BY USAGE, 2017-2024 (USD BILLION)
  • TABLE 61: IN-CENTER DIALYSIS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 62: IN-CENTER DIALYSIS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 63: HOSPITAL DIALYSIS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 64: INDEPENDENT IN-CENTER DIALYSIS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 65: HOME DIALYSIS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 66: HOME DIALYSIS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 67: PERITONEAL DIALYSIS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 68: HOME HEMODIALYSIS MARKET , BY REGION, 2017-2024 (USD BILLION)
  • TABLE 69: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 70: NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 71: NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 72: NORTH AMERICA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 73: NORTH AMERICA: HEMODIALYSIS MARKET, BY MODALITY, 2017-2024 (USD BILLION)
  • TABLE 74: NORTH AMERICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 75: NORTH AMERICA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 76: NORTH AMERICA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2017-2024(USD BILLION)
  • TABLE 77: NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY USAGE, 2017-2024(USD BILLION)
  • TABLE 78: US: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 79: US: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 80: US: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 81: CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 82: CANADA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 83: CANADA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 84: EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 85: EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 86: EUROPE: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 87: EUROPE: HEMODIALYSIS MARKET, BY MODALITY, 2017-2024 (USD BILLION)
  • TABLE 88: EUROPE: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 89: EUROPE: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 90: EUROPE: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2017-2024 (USD BILLION)
  • TABLE 91: EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY USAGE, 2017-2024(USD BILLION)
  • TABLE 92: GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 93: GERMANY: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 94: GERMANY: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 95: FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 96: FRANCE: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 97: FRANCE: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 98: UK: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 99: UK: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 100: UK: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 101: REST OF EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 102: REST OF EUROPE: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 103: REST OF EUROPE: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 104: ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2017-2024 (USD BILLION)
  • TABLE 105: ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 106: ASIA PACIFIC: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 107: ASIA PACIFIC: HEMODIALYSIS MARKET, BY MODALITY, 2017-2024 (USD BILLION)
  • TABLE 108: ASIA PACIFIC: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 109: ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 110: ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2017-2024 (USD BILLION)
  • TABLE 111: ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY USAGE, 2017-2024 (USD BILLION)
  • TABLE 112: JAPAN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 113: JAPAN: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 114: JAPAN: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 115: CHINA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 116: CHINA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 117: CHINA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 118: INDIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 119: INDIA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 120: INDIA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 121: ROAPAC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 122: ROAPAC: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 123: ROAPAC: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 124: ROW: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • TABLE 125: ROW: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 126: ROW: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 127: ROW: HEMODIALYSIS MARKET, BY MODALITY, 2017-2024 (USD BILLION)
  • TABLE 128: ROW: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 129: ROW: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 130: ROW: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2017-2024 (USD BILLION)
  • TABLE 131: ROW: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY USAGE, 2017-2024 (USD BILLION)
  • TABLE 132: LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 133: LATIN AMERICA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 134: LATIN AMERICA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 135: MIDDLE EAST: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 136: MIDDLE EAST: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 137: MIDDLE EAST: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 138: AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 139: AFRICA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)
  • TABLE 140: AFRICA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD BILLION)

LIST OF FIGURES

  • FIGURE 1: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 4: BOTTOM-UP APPROACH MARKET SIZE ESTIMATION: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
  • FIGURE 5: TOP-DOWN APPROACH MARKET SIZE ESTIMATION: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
  • FIGURE 6: RESEARCH METHODOLOGY: TOP-DOWN APPROACH (FOR HD AND PD DIALYSIS SERVICES MARKET)
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, BY TYPE & REGION, 2019 (USD BILLION)
  • FIGURE 9: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD BILLION)
  • FIGURE 10: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2019 VS. 2024 (USD BILLION)
  • FIGURE 11: DIALYSIS WATER TREATMENT SYSTEMS MARKET SHARE, BY TYPE, 2019 VS. 2024
  • FIGURE 12: HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SHARE, BY USAGE, 2019 VS. 2024
  • FIGURE 13: HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, BY REGION
  • FIGURE 14: INCREASING NUMBER OF ESRD PATIENTS TO DRIVE THE GROWTH OF THE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: HEMODIALYSIS SEGMENT IS EXPECTED TO DOMINATE THE GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: HEMODIALYSIS SERVICES TO REGISTER THE HIGHEST GROWTH IN THE HEMODIALYSIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: SHORT DAILY HEMODIALYSIS SEGMENT TO REGISTER THE HIGHEST CAGR IN THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: PERITONEAL DIALYSIS CONCENTRATES/DIALYSATE SEGMENT TO DOMINATE THE PERITONEAL DIALYSIS PRODUCTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 19: AUTOMATED PERITONEAL DIALYSIS SEGMENT TO REGISTER THE HIGHEST CAGR IN THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: NORTH AMERICA TO DOMINATE THE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET IN 2019
  • FIGURE 21: INDIA TO WITNESS THE HIGHEST CAGR DURING THE FORECAST PERIOD (2019-2024)
  • FIGURE 22: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 23: NUMBER OF PATIENTS WITH RENAL DISORDERS, BY TREATMENT TYPE
  • FIGURE 24: NUMBER OF DIALYSIS PATIENTS, BY REGION, 2017
  • FIGURE 25: EMERGING MARKETS REPRESENT A LARGE UNTREATED PATIENT POPULATION
  • FIGURE 26: REIMBURSEMENT SCENARIO FOR DIALYSIS (2017)
  • FIGURE 27: LEVEL OF REIMBURSEMENT FOR HD AND PD ACROSS KEY COUNTRIES IN EUROPE, 2017
  • FIGURE 28: EUROPE: VARIANCE IN REIMBURSEMENT STRUCTURES
  • FIGURE 29: DIALYSIS REIMBURSEMENT COVERAGE IN ASIA PACIFIC COUNTRIES (2015)
  • FIGURE 30: KEY REGULATORY BODIES INVOLVED IN THE APPROVAL OF NEW DIALYSIS PRODUCTS
  • FIGURE 31: NORTH AMERICA: HEMODIALYSIS AND PERITONEAL MARKET SNAPSHOT
  • FIGURE 32: EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT
  • FIGURE 33: ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT
  • FIGURE 34: ROW: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT
  • FIGURE 35: KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, 2015-2019
  • FIGURE 36: FRESENIUS TO BE THE LEADING COMPANY IN THE DIALYSIS MARKET DUE TO ITS LEADERSHIP IN ALL SEGMENTS
  • FIGURE 37: GLOBAL HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SHARE, BY KEY PLAYER, 2018
  • FIGURE 38: GLOBAL HEMODIALYSIS PRODUCTS MARKET SHARE, BY KEY PLAYERS, 2018
  • FIGURE 39: TOP DIALYSIS SERVICES PROVIDERS, BY REGION, 2018
  • FIGURE 40: KEY PLAYERS IN THE PERITONEAL DIALYSIS PRODUCTS MARKET, 2018
  • FIGURE 41: VENDOR DIVE: EVALUATION OVERVIEW
  • FIGURE 42: SCORING METHODOLOGY
  • FIGURE 43: COMPARISON OF COMPETITIVE INTENSITY SCORES: FRESENIUS, BAXTER, AND B. BRAUN
  • FIGURE 44: ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2017)
  • FIGURE 45: BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 46: B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2018)
  • FIGURE 47: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2018)
  • FIGURE 48: CANTEL MEDICAL CORPORATION.: COMPANY SNAPSHOT (2018)
  • FIGURE 49: DAVITA HEALTHCARE PARTNERS INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 50: FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT (2018)
  • FIGURE 51: MEDTRONIC PLC: COMPANY SNAPSHOT (2018)
  • FIGURE 52: NIPRO CORPORATION: COMPANY SNAPSHOT (2017)
  • FIGURE 53: NIKKISO CO., LTD: COMPANY SNAPSHOT (2017)
  • FIGURE 54: ROCKWELL MEDICAL, INC.: COMPANY SNAPSHOT (2018)
目次
Product Code: MD 2157

"The hemodialysis and peritoneal dialysis market is projected to grow at a CAGR of 6.0% during the forecast period."

The hemodialysis and peritoneal dialysis market is projected to reach USD 99.2 billion by 2024 from USD 74.2 billion in 2019, at a CAGR of 6.0%. Growth in this market is largely driven by factors such as the increasing number of ESRD patients, growing prevalence of diabetes & hypertension, preference for dialysis treatments over kidney transplants, and initiatives taken by leading players to introduce advanced products & services. However, the risks & complications associated with dialysis, low consumer awareness regarding kidney diseases, and reimbursement concerns are expected to restrain the growth of this market during the forecast period.

"The hemodialysis segment is expected to account for the largest market share during the forecast period."

The hemodialysis and peritoneal dialysis market is categorized into two broad segments, namely, hemodialysis and peritoneal dialysis. The hemodialysis segment is expected to account for the largest share of the market. Factors such as the huge acceptance of hemodialysis therapy over peritoneal dialysis among CKD and ESRD patients, an increasing number of ESRD patients, growth in the number of dialysis centers, and government initiatives are stimulating the growth of the hemodialysis market.

"The conventional hemodialysis segment is expected to hold the largest share of the hemodialysis modality market during the forecast period."

Based on modality, the hemodialysis market is classified into three major segments-conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis (NHD). The conventional hemodialysis segment is expected to account for the largest share of this market in 2019. The large share of this segment can be attributed to the large patient population opting for conventional dialysis, rising number of dialysis centers across the globe, a growing number of ESRD patients, and ongoing technological advancements in conventional hemodialysis.

"North America to account for the largest share of the global market in 2019."

Based on region, the hemodialysis and peritoneal dialysis market has been segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the hemodialysis and peritoneal dialysis market in 2019. The higher per capita income as compared to other regions, favorable reimbursement scenario, and increasing demand for dialysis procedures are propelling the growth of the in-center dialysis market.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1- 45%, Tier 2 - 34%, and Tier 3 -21%
  • By Designation: C-level - 14%, Director-level - 10%, and Others - 76%
  • By Region: Europe - 35%, North America - 32%, APAC - 25%, and RoW - 8%

The major players in the market include: Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (US), Baxter International, Inc. (US), and B. Braun Melsungen AG (Germany), are key players dominating the market. Other players in this market include Ion Nipro Corporation (Japan), Cantel Medical Corporation (US), NIKKISO CO., LTD (Japan), Diaverum Healthcare Partners (Germany), Asahi Kasei Corporation (Japan), Medtronic Plc (Ireland), Rockwell Medical, Inc. (US), Becton, Dickinson and Company (US), Dialife Group (Switzerland), and Isopure Corp. (US), among others.

Research Coverage:

This report studies the hemodialysis and peritoneal dialysis market based on type, product & service, modality, and usage. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).

Key Benefits of Buying the Report:

This report analyzes industry trends, market shares of top players, and company profiles, which together form a basic view of the market. It also analyzes the competitive landscape; emerging segments of the hemodialysis and peritoneal dialysis market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Breakdown of primaries
  • 2.2. MARKET SIZE ESTIMATION METHODOLOGY
    • 2.2.1. PRODUCT-BASED MARKET ESTIMATION
  • 2.3. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.4. RESEARCH LIMITATIONS AND ASSUMPTIONS
    • 2.4.1. LIMITATIONS
    • 2.4.2. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. HEMODIALYSIS & PERITONEAL DIALYSIS: MARKET OVERVIEW
  • 4.2. HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SHARE, BY TYPE, 2019 VS 2024
  • 4.3. HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2019 VS 2024(USD BILLION)
  • 4.4. HEMODIALYSIS MARKET, BY MODALITY, 2019 VS 2024(USD BILLION)
  • 4.5. PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019 VS 2024(USD BILLION)
  • 4.6. PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019 VS 2024(USD BILLION)
  • 4.7. REGIONAL ANALYSIS: HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, BY USAGE
  • 4.8. HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, BY COUNTRY

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing number of ESRD patients
      • 5.2.1.2. Growing prevalence of diabetes and hypertension
      • 5.2.1.3. Shortage of organ donors and risks associated with transplant
      • 5.2.1.4. Technological advancements and new product launches
      • 5.2.1.5. Rising R&D expenditure for developing new dialysis products
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Risks and complications associated with dialysis
      • 5.2.2.2. Product recalls
      • 5.2.2.3. Reimbursement concerns in emerging markets
      • 5.2.2.4. Stringent regulatory policies for the approval and manufacturing of dialysis products
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging markets
      • 5.2.3.2. Development of user-friendly and low-cost dialysis products
      • 5.2.3.3. Increasing number of dialysis centers
      • 5.2.3.4. Growing preference for home hemodialysis(HHD) treatment
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Benefits of renal transplantation
        • 5.2.4.1.1. Low-cost solution
        • 5.2.4.1.2. Better patient survival rate
      • 5.2.4.2. Sustainability of small and medium-sized companies in the highly competitive market
  • 5.3. INDUSTRY TRENDS
    • 5.3.1. FOCUS ON WEARABLE AND MINIATURE DIALYSIS MACHINES
    • 5.3.2. CONSOLIDATION OF THE DIALYSIS SERVICES MARKET
    • 5.3.3. PARTNERSHIPS AMONG DIALYSIS PRODUCT AND SERVICE PROVIDERS
    • 5.3.4. ROBUST PRIVATE EQUITY ACTIVITY
    • 5.3.5. INCREASING PREFERENCE FOR PRIVATE DIALYSIS PROVIDERS
  • 5.4. REIMBURSEMENT SCENARIO
    • 5.4.1. NORTH AMERICA
    • 5.4.2. EUROPE
      • 5.4.2.1. Germany
      • 5.4.2.2. France
      • 5.4.2.3. Belgium
      • 5.4.2.4. UK
      • 5.4.2.5. Netherlands
    • 5.4.3. ASIA PACIFIC
      • 5.4.3.1. Asia(Except Japan)
      • 5.4.3.2. Japan
      • 5.4.3.3. Pacific region
  • 5.5. REGULATORY LANDSCAPE
    • 5.5.1. NORTH AMERICA
      • 5.5.1.1. US
      • 5.5.1.2. Canada
    • 5.5.2. EUROPE
    • 5.5.3. ASIA PACIFIC
      • 5.5.3.1. India
      • 5.5.3.2. China
      • 5.5.3.3. Japan
      • 5.5.3.4. South Korea
    • 5.5.4. REST OF THE WORLD
      • 5.5.4.1. Latin America
        • 5.5.4.1.1. Brazil
        • 5.5.4.1.2. Mexico
      • 5.5.4.2. Middle East
      • 5.5.4.3. Africa

6. HEMODIALYSIS MARKET

  • 6.1. HEMODIALYSIS MARKET, BY PRODUCTS & SERVICES
    • 6.1.1. INTRODUCTION
    • 6.1.2. HEMODIALYSIS SERVICES
      • 6.1.2.1. In-center hemodialysis services
        • 6.1.2.1.1. Growth in patient base and support for treatment are driving the demand for in-center services
      • 6.1.2.2. Home hemodialysis services
        • 6.1.2.2.1. Poor reimbursement scenario for HHD has hindered market growth
    • 6.1.3. HEMODIALYSIS PRODUCTS
      • 6.1.3.1. Hemodialysis machines
        • 6.1.3.1.1. Center-use hemodialysis machines
        • 6.1.3.1.1.1. Increasing number of renal care centers has ensured a steady demand for center-use machines
        • 6.1.3.1.2. Home-use hemodialysis machines
        • 6.1.3.1.2.1. HHD machines have gained significance due to their improved clinical outcomes & better quality of life for patients
      • 6.1.3.2. Hemodialysis consumables & supplies
        • 6.1.3.2.1. Dialyzers
        • 6.1.3.2.2. Dialyzers market, by material type
        • 6.1.3.2.2.1. Synthetic dialyzers
        • 6.1.3.2.2.1.1. Ease of sterilization, high strength, and resistance of synthetic dialyzers account for their wide use
        • 6.1.3.2.2.2. Cellulose-based dialyzers
        • 6.1.3.2.2.2.1. High biocompatibility and affordability have enabled market growth
        • 6.1.3.2.3. Dialyzers market, by flux type
        • 6.1.3.2.3.1. High-flux Dialyzers
        • 6.1.3.2.3.1.1. High-flux dialyzers can clear medium-sized molecules and prevent the removal of proteins from the blood
        • 6.1.3.2.3.2. Low-flux Dialyzers
        • 6.1.3.2.3.2.1. Capability to remove smaller-sized molecules have made low-flux dialyzers popular
        • 6.1.3.2.4. Bloodlines
        • 6.1.3.2.4.1. Bloodline reuse in emerging markets is a key challenge to the growth of this segment
        • 6.1.3.2.5. Concentrates/Dialysates
        • 6.1.3.2.5.1. Maintaining the quality of concentrates is a key challenge for market players
        • 6.1.3.2.6. Access products
        • 6.1.3.2.6.1. AV Fistula Needles
        • 6.1.3.2.6.1.1. AV fistula access provides better blood flow and lower risk of infections
        • 6.1.3.2.6.2. Arteriovenous Grafts
        • 6.1.3.2.6.2.1. Synthetic AV grafts are more widely used than their biological counterparts are
        • 6.1.3.2.6.3. Central Venous Catheters
        • 6.1.3.2.6.3.1. Catheters can be used in the long term if grafts and fistulas are unsuccessful
        • 6.1.3.2.7. Other hemodialysis consumables
  • 6.2. HEMODIALYSIS MARKET, BY MODALITY
    • 6.2.1. CONVENTIONAL LONG-TERM HEMODIALYSIS
      • 6.2.1.1. Technological advancements and rising number of dialysis centers are driving market growth
    • 6.2.2. SHORT DAILY HEMODIALYSIS
      • 6.2.2.1. Daily HD has demonstrated better outcomes than conventional HD
    • 6.2.3. NOCTURNAL HEMODIALYSIS
      • 6.2.3.1. Rising awareness will drive demand for NHD in the coming years
  • 6.3. WATER TREATMENT SYSTEMS MARKET, BY TYPE
    • 6.3.1. CENTRAL WATER DISINFECTION SYSTEMS
      • 6.3.1.1. Chemical disinfection systems
        • 6.3.1.1.1. Chemical disinfection systems segment to dominate the central water disinfection systems market during the forecast period
      • 6.3.1.2. Heat disinfection systems
        • 6.3.1.2.1. Heat disinfection lowers the labor costs and disposal issues associated with disinfection using chemicals
      • 6.3.1.3. Accessories
    • 6.3.2. PORTABLE WATER DISINFECTION SYSTEMS
      • 6.3.2.1. Chemical disinfection systems
        • 6.3.2.1.1. Development of new ozone disinfection systems with high safety and efficacy profiles to drive market growth
      • 6.3.2.2. Heat disinfection systems
        • 6.3.2.2.1. Launch of advanced portable heat disinfection systems to drive market growth
      • 6.3.2.3. Accessories

7. PERITONEAL DIALYSIS MARKET

  • 7.1. PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE
    • 7.1.1. INTRODUCTION
    • 7.1.2. PRODUCTS
      • 7.1.2.1. Peritoneal dialysis concentrates/dialysates
        • 7.1.2.1.1. High demand for PD concentrates has prompted players to focus on improving their manufacturing capabilities for PD products
      • 7.1.2.2. Peritoneal dialysis machines
        • 7.1.2.2.1. Emerging countries are witnessing growing adoption of home peritoneal dialysis treatments
      • 7.1.2.3. Peritoneal dialysis catheters
        • 7.1.2.3.1. Development of new approaches for PD catheter placement is driving their adoption
      • 7.1.2.4. Peritoneal dialysis transfer sets
        • 7.1.2.4.1. Baxter International and Fresenius Medical Care are the major providers of PD transfer sets
      • 7.1.2.5. Other peritoneal dialysis products
    • 7.1.3. PERITONEAL DIALYSIS SERVICES
      • 7.1.3.1. Self-administrative nature of PD leading to the slow growth of the services market
  • 7.2. PERITONEAL DIALYSIS MARKET, BY MODALITY
    • 7.2.1. CONTINUOUS AMBULATORY PERITONEAL DIALYSIS
      • 7.2.1.1. CAPD offers a wide range of advantages over APD
    • 7.2.2. AUTOMATED PERITONEAL DIALYSIS
      • 7.2.2.1. Risk of rapid decline in residual renal functions with APD to limit its adoption

8. HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, BY USAGE

  • 8.1. INTRODUCTION
  • 8.2. IN-CENTER DIALYSIS
    • 8.2.1. HOSPITAL DIALYSIS
      • 8.2.1.1. Increasing government support to develop dialysis treatment facilities in hospitals to propel the growth of this market segment
    • 8.2.2. INDEPENDENT DIALYSIS
      • 8.2.2.1. Changing reimbursement policies in developed countries and a scarcity of skilled nephrologists are key restraints for market growth
  • 8.3. HOME DIALYSIS
    • 8.3.1. PERITONEAL DIALYSIS
      • 8.3.1.1. Technological improvements, freedom for patients to travel during treatment, and fewer dietary restrictions are driving the growth of the peritoneal dialysis market
    • 8.3.2. HOME HEMODIALYSIS(HHD)
      • 8.3.2.1. Advantages such as a higher dose of dialysis, improved quality of life, and better clinical outcomes are majorly responsible for the growing demand for HHD among patients

9. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
      • 9.2.1.1. Bundled reimbursement is a strong incentive for dialysis providers to encourage the adoption of home PD
    • 9.2.2. CANADA
      • 9.2.2.1. The shortage of dialysis facilities is restraining the growth of the market in Canada
  • 9.3. EUROPE
    • 9.3.1. GERMANY
      • 9.3.1.1. Germany is the only country in Europe where PD is better reimbursed than HD
    • 9.3.2. FRANCE
      • 9.3.2.1. High cost of dialysis treatment and variations in reimbursement policies are restraining market growth
    • 9.3.3. UK
      • 9.3.3.1. The number of new dialysis centers being established in the country is expected to drive the market
    • 9.3.4. REST OF EUROPE
  • 9.4. ASIA PACIFIC
    • 9.4.1. JAPAN
      • 9.4.1.1. High prevalence of ESRD to support market growth in Japan
    • 9.4.2. CHINA
      • 9.4.2.1. Growing prevalence of diabetes and hypertension to drive market growth
    • 9.4.3. INDIA
      • 9.4.3.1. India to register the highest growth rate in the global hemodialysis and peritoneal dialysis market during the study period
    • 9.4.4. REST OF ASIA PACIFIC(ROAPAC)
  • 9.5. REST OF THE WORLD
    • 9.5.1. LATIN AMERICA
      • 9.5.1.1. Latin America dominates the hemodialysis and peritoneal dialysis market in the RoW due to a large number of dialysis patients in the region
    • 9.5.2. MIDDLE EAST
      • 9.5.2.1. Increasing number of ESRD patients and the growing number of dialysis centers to drive market growth
    • 9.5.3. AFRICA
      • 9.5.3.1. Poor economic condition and the high cost of dialysis treatment to hamper market growth

10. COMPETITIVE LANDSCAPE

  • 10.1. INTRODUCTION
  • 10.2. MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018
    • 10.2.1. KEY PLAYERS IN THE HEMODIALYSIS PRODUCTS MARKET
    • 10.2.2. KEY PLAYERS IN THE DIALYSIS SERVICES MARKET
    • 10.2.3. KEY PLAYERS IN THE PERITONEAL DIALYSIS PRODUCTS MARKET
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. PRODUCT LAUNCHES AND APPROVALS
    • 10.3.2. EXPANSIONS
    • 10.3.3. MERGERS & ACQUISITIONS
    • 10.3.4. PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
  • 10.4. VENDOR DIVE OVERVIEW
  • 10.5. VENDOR INCLUSION CRITERIA
  • 10.6. VENDOR DIVE
    • 10.6.1. VISIONARY LEADERS
    • 10.6.2. INNOVATORS
    • 10.6.3. DYNAMIC DIFFERENTIATORS
    • 10.6.4. EMERGING COMPANIES
  • 10.7. COMPETITIVE INTENSITY: DIALYSIS PRODUCTS MARKET
    • 10.7.1. EVALUATION PARAMETERS AND SCORES
    • 10.7.2. SCORING METHODOLOGY
    • 10.7.3. COMPETITIVE INTENSITY SCORE, BY COMPANY
      • 10.7.3.1. Fresenius Medical Care AG & Co. KGaA
      • 10.7.3.2. Baxter International, Inc.
      • 10.7.3.3. B. Braun Melsungen AG
    • 10.7.4. COMPETITIVE INTENSITY - MAPPING OF BAXTER, B. BRAUN, AND FRESENIUS

11. COMPANY PROFILES (Business Overview, Service Offered, Products Offered, Recent Developments, MnM View)*

  • 11.1. ASAHI KASEI MEDICAL CO., LTD.(A SUBSIDIARY OF ASAHI KASEI CORPORATION)
  • 11.2. BAXTER INTERNATIONAL INC.
  • 11.3. B. BRAUN MELSUNGEN AG
  • 11.4. BECTON, DICKINSON AND COMPANY
  • 11.5. CANTEL MEDICAL CORPORATION
  • 11.6. DAVITA INC.
  • 11.7. DIAVERUM
  • 11.8. DIALIFE GROUP
  • 11.9. FRESENIUS MEDICAL CARE AG & CO. KGAA
  • 11.10. ISOPURE CORP
  • 11.11. MEDTRONIC PLC
  • 11.12. NIPRO CORPORATION
  • 11.13. NIKKISO CO., LTD.
  • 11.14. ROCKWELL MEDICAL, INC.
  • 11.15. TORAY MEDICAL CO., LTD.

*Business Overview, Service Offered, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3. AVAILABLE CUSTOMIZATIONS
  • 12.4. RELATED REPORTS
  • 12.5. AUTHOR DETAILS
Back to Top